Subscribe to our: Posted on 2007/10/18 16:39:15 (5935 reads)
Diosynth Biotechnology Announces Supply Agreement Extension with Pfizer for Production of a Recombinant Protein DrugRead More... | 4382 bytes more
Posted on 2007/5/2 9:50:00 (5891 reads)
Diosynth Biotechnology announced today that it has signed an agreement with VGX Pharmaceuticals for process development activities and cGMP production of clinical trial material for their biological therapeutic drug candidate VGX-100. Read More... | 8194 bytes more
Posted on 2007/4/2 10:50:00 (4320 reads)
Diosynth Biotechnology announces agreement with Talecris Biotherapeutics for Process Development and Clinical Production of Recombinant Plasminogen.
Read More... | 5039 bytes more
Posted on 2007/2/7 10:40:00 (4216 reads)
Diosynth Biotechnology signed an extension of its exclusive agreement with PDL BioPharma, Inc. for the commercial manufacture of Retavase®
Read More... | 4936 bytes more
Posted on 2007/1/26 20:00:00 (4235 reads)
Jacques van Kimmenaede has been appointed President of Diosynth Biotechnology in RTP, NC, USA. He joins Diosynth Biotechnology from Organon where he held senior executive management positions in manufacturing and global marketing.
Read More... | 4143 bytes more
|
Biotechnology Contract Manufacturing Services
